Dissecting the signaling pathways that mediate cancer in PTEN and LKB1 double-knockout mice

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• PTEN (phosphatase and tensin homolog) and LKB1 (liver kinase B1) are crucial tumor suppressors.
• Loss of these genes in mice leads to spontaneous cancer development.
• Key signaling pathways involving AKT and mTORC1 are implicated in carcinogenesis.

Purpose of the Study:

• To investigate the roles of PTEN and LKB1 in cancer development.
• To elucidate the mechanisms by which PTEN and LKB1 loss contribute to tumor progression.
• To understand the interplay between AKT, mTORC1, and immune evasion in PTEN/LKB1-deficient cancers.

Main Methods:

• Utilizing a mouse model with a double knockout of PTEN and LKB1 genes.
• Analyzing the activation status of AKT and mTORC1 signaling pathways.
• Investigating the expression of programmed death-ligand 1 (PD-L1) in tumor cells.

Main Results:

• The double knockout of PTEN and LKB1 promotes spontaneous tumor formation.
• Activated AKT and mTORC1 signaling pathways are observed in these tumors.
• mTORC1 drives tumor initiation and progression via cell growth and survival.
• Activated AKT independently induces PD-L1, facilitating immune evasion.

Conclusions:

• Simultaneous loss of PTEN and LKB1 creates a pro-tumorigenic environment.
• AKT and mTORC1 activation are central to cancer development following PTEN/LKB1 loss.
• The induction of PD-L1 by AKT is a critical mechanism for immune escape in these cancers.